The incidence of chronic mastitis has soared, and women should be alert to ＂immortal cancer＂
editorial comment/note
Chronic mastitis is called "immortal cancer" because it is easy to be misdiagnosed, difficult to treat and has a high recurrence rate. It causes no less pain to women than breast cancer, which will cause unbearable pain, pus and ulceration of women’s breasts, and even cause lifelong disability after breast resection. In recent years, the incidence of chronic mastitis has increased rapidly, which seriously threatens women’s health. It is estimated that one in every 50 women aged 15-47 in China suffers from chronic mastitis such as granulomatous mastitis. In southern cities, one in every 20 people suffers from this disease on average.
The prevalence of chronic mastitis is mainly related to heredity and breast trauma, and it is also inseparable from the unhealthy lifestyle of contemporary women, such as improper marriage and childbearing, abuse of environmental estrogen and estrogen drugs, frequent use of hormonal drugs such as emergency contraception and unscientific "maintenance" methods such as breast augmentation massage. Experts appeal that the treatment of chronic mastitis is currently facing the dilemma of "misdiagnosis and mistreatment", and society and women should pay more attention to chronic mastitis.
Experts suggest that female friends should improve their self-health management level. From the age of 20, women should have a self-examination of their breasts once a month and a regular breast examination every three years; From the age of 40, it is necessary to have a special breast examination once a year, including mammography, molybdenum palladium phase, nuclear magnetic resonance and ultrasound examination. Once breast lesions or abnormalities are found in breast self-examination or general survey, you should seek medical treatment as soon as possible, and find, diagnose and treat them early.
When Xiao Zhang, a girl from Henan who is about to get married, took a bath not long ago, she felt a lump the size of a broad bean on her left breast. Because she was in a hurry to get married, she didn’t take it to heart. Unexpectedly, the lump increased rapidly and the skin was red. Xiao Zhang went to the hospital and was diagnosed as plasma cell mastitis. The doctor said that if we wait any longer, the breast may fester and fester, and it needs to be surgically removed … … Plasma cell mastitis (duct ectasia) is a common chronic mastitis, together with areola fistula and granulomatous mastitis. In recent years, the incidence rate has increased rapidly, which seriously threatens women’s health.
Chronic mastitis is no less painful than breast cancer, and it is easy to be misdiagnosed and difficult to treat with a high recurrence rate.
Professor Huang Hanyuan, a famous breast disease expert in Peking Union Medical College Hospital, said in an interview with China Women’s Daily and China Women’s Network that patients with chronic mastitis, especially plasma cell mastitis, suffer as much as breast cancer, and at present, chronic mastitis is facing the dilemma of "misdiagnosis and mistreatment". Because the treatment of these diseases is very difficult and the recurrence rate is high, it is easy to cause medical disputes, and because of the shortage of medical resources in public hospitals, it will tilt towards more serious breast cancer patients. This is undoubtedly worse for sick women, and he called on society and women to pay more attention to chronic mastitis.
Professor Huang Hanyuan, who is 87 years old, has been a doctor for 60 years. He has treated countless patients with breast diseases and completed tens of thousands of breast cancer operations. In recent years, he has devoted himself to the study of chronic breast diseases and completed thousands of operations on plasma cell mastitis. He told reporters: "At present, the medical community pays more attention to breast cancer research and makes rapid progress. The scarce public medical resources will be tilted towards breast cancer patients. Therefore, what I am most worried about is not breast cancer patients, but plasma cell mastitis and granulomatous mastitis patients. "
Although plasma cell mastitis will not become cancerous, surgery can also cure chronic mastitis. But once you get this disease, the breast will suddenly have a lump, the pain will be unbearable, and the later stage will burst and purulent, which will make the patient miserable. If you don’t treat it in time, you will also face the danger of breast resection.
Heredity, estrogen abuse, breast enhancement and maintenance are all incentives, and breast diseases cannot be completely eliminated.
It is estimated that one in every 50 women aged 15-47 (mostly under 36) in China suffers from granulomatous mastitis. In southern cities, one in every 20 people suffers from this disease on average.
Heredity and breast trauma are the main factors of illness, and may be related to modern lifestyles, such as improper marriage and childbearing, abuse of environmental estrogen and estrogen drugs, frequent use of hormonal drugs such as emergency contraceptives, and unscientific "maintenance" methods such as breast augmentation massage.
Plasma cell mastitis is also a major problem in breast surgery. Professor Huang Hanyuan introduced that at present, the medical treatment of purulent mastitis in acute lactation is relatively mature, but there are many puzzles about chronic mastitis. On the one hand, the breast lumps in the early stage of plasma cell mastitis and granulomatous mastitis are very similar to breast cancer and are easily misdiagnosed as breast cancer; In addition to misdiagnosis, the high recurrence rate is also one of the reasons why chronic mastitis is difficult to treat.
"It may only take me about an hour to do a breast cancer operation, but it takes five or six hours to do a serous surgery, because the lesions are like watermelon seeds in watermelons. If one is not picked out, it will recur. The recurrence rate is as high as 30%." In recent 20 years, Huang Hanyuan has devoted himself to the study of plasma cell mastitis and granulomatous mastitis, and developed a surgical treatment mode. The postoperative recurrence rate is less than 2%, far below the international recurrence rate of 30%.
At present, the clinical treatment for patients with plasma cell mastitis and granulomatous mastitis is "simple mastectomy". Although this is the most direct and least risky for the eradication of breast diseases, and it has been included in the scope of medical insurance reimbursement, the loss of double breasts will cause lifelong disability and make patients suffer more mental pain.
Professor Huang Hanyuan believes that breast surgery is different from general surgery, and the breast has its particularity. Its beauty and function are very important for women and families, so you can’t treat the breast as a belly. In recent years, Professor Huang Hanyuan applied flap transfer to the clinical treatment of serous milk and granuloma, and achieved the integration of surgery and plastic surgery. Skin flap transfer is often used in plastic surgery and orthopedic surgery to repair wounds and organ defects, such as ear and nose defects. The application of skin flap transfer technology in the treatment of plasma cell mastitis has saved many patients with serious lesions who can not keep their breasts from mastectomy.
Women should strengthen breast health self-management, check regularly to prevent problems before they happen.
In recent years, women’s awareness of preventing breast diseases has been continuously improved. On the other hand, many women are overly sensitive and talk about "pain" discoloration, such as breast pain before and after menstruation, and some women doubt whether they have breast cancer. Professor Huang Hanyuan explained that premenstrual breast pain in women does not necessarily indicate breast diseases, most of which are normal premenstrual hyperplasia and generally do not need clinical treatment.
Professor Huang Hanyuan said that ovulation is about 1-2 weeks before menstruation, which is the peak of estrogen secretion in women. Estrogen can promote the development of mammary duct and lead to water and sodium retention between tissues. Therefore, premenstrual women’s breasts are larger than usual, and they are often accompanied by edema and pain. At the same time, on the basis of estrogen secretion, progesterone secretion also gradually increased, further promoting the development of the breast. About 10 days after ovulation (when the menstrual period begins), the corpus luteum will begin to degenerate, and the levels of estrogen and progesterone will decrease rapidly, so that the mammary gland will stop developing and the phenomenon of breast pain will disappear.
However, if the estrogen level of women is still high when menstruation comes, the premenstrual breast enlargement will not recover during menstruation, and the pain will persist, which will form clinical breast hyperplasia. However, most people suffer from simple lobular hyperplasia, which is not serious. At this time, although the breast is painful, the breast is not red and swollen, and there is no abnormal secretion in the nipple. This does not mean that breast inflammation and breast cancer have occurred, although it also appears in the form of a lump, but it is a benign hyperplasia of breast stroma rather than a malignant tumor. Only a few serious hyperplasia can become cancerous.
"The majority of female friends should improve their self-health management level." Professor Huang Hanyuan suggested that from the age of 20, women should have a self-examination of their breasts once a month and a regular breast examination every three years; From the age of 40, it is necessary to have a special breast examination once a year, including mammography, molybdenum palladium phase, nuclear magnetic resonance and ultrasound examination. Once breast lesions or abnormalities are found in breast self-examination or general survey, you should seek medical treatment as soon as possible, so as to achieve the purpose of early detection, early diagnosis and early treatment. (China Women’s Daily China Women’s Network reporter Peng Yu)